Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Bankole Johnson
University of Maryland Baltimore, Department: Psychiatry
Should you be removed from our database? Contact us at [email protected]. Read more below.
Adial Pharmaceuticals Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Bankole Johnson is an unpaid consultant for this grant, and is a founder of Adial Pharmaceuticals. Additionally, he currently serves as chair of the baord of directors, is a paid consultant, and holds substantial equity in the company. Adial Pharmaceuticals is a manufacturer of Odansetron, the compound under study in this research.
1/2-Pharmacogenetic Treatments for Alcoholism
This proposal is to extend findings from a randomized double-blind clinical trial of ondansetron, in which the medication was found to reduce drinking among individuals with certain genotypes (i.e., forms of DNA, the material that controls the inheritance of characteristics). The proposed study will address a number of limitations in the prior work, including testing the medication in both European-American and African-American samples. To ensure an adequate number of participants, the study will be conducted at both the University of Virginia and the University of Pennsylvania, by researchers with considerable experience in the conduct of such studies.
Filed on March 17, 2015.
Tell us what you know about Bankole Johnson's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Bankole Johnson”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Bankole Johnson | University of Maryland Baltimore | Conflict of Interest | Adial Pharmaceuticals Inc. | $250,000 - $299,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.